Research Topics
Species | Rie HoriiSummaryAffiliation: Cancer Institute Hospital Country: Japan Publications
| Collaborators
|
Detail Information
Publications
Spontaneous " healing" of breast cancerRie Horii
Department of Breast Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, 3 10 6, Ariake, Koto ku, Tokyo 135 8550, Japan
Breast Cancer 12:140-4. 2005..Healing is a phenomenon by which the intraductal component of breast cancer disappears and is replaced by fibrous tissue. Focally localized healing often prevents confirmation of the continuity of intraductal carcinoma...
Histological features of breast cancer, highly sensitive to chemotherapyRie Horii
Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Koto ku, Tokyo, 135 8550, Japan
Breast Cancer 14:393-400. 2007..To establish tailor-made therapy for breast cancer, we investigated the possibility of predicting chemotherapy sensitive cases based on pre-therapeutic histological features...
Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancerR Horii
Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
Br J Cancer 97:654-8. 2007..Endocrine monotherapy may be sufficient as adjuvant treatment in the intermediate-risk patients, in which only one risk factor was present without any metastatic involvement in lymph node...
Muco-epidermoid carcinoma of the breastRie Horii
Department of Breast Pathology, Cancer Institute of Japanese Foundation for Cancer Research, Tokyo, Japan
Pathol Int 56:549-53. 2006..These histological features confirmed the diagnosis as muco-epidermoid carcinoma of the breast. This is the first report of muco-epidermoid carcinoma of the breast in Japan...
Assessment of hormone receptor status in breast cancerRie Horii
Department of Pathology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
Pathol Int 57:784-90. 2007..When assessing hormone receptors of breast cancer in routine clinical settings, it is sufficient to determine the proportion of positive cells in the entire cancer area...
Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapyTomo Osako
Division of Pathology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3 10 6, Ariake, Koto ku, Tokyo, 135 8550, Japan
J Cancer Res Clin Oncol 136:233-41. 2010....
High-grade breast cancers include both highly sensitive and highly resistant subsets to cytotoxic chemotherapyTomo Osako
Divisions of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3 8 31, Ariake, Koto ku, Tokyo, 135 8550, Japan
J Cancer Res Clin Oncol 136:1431-8. 2010..To determine the highly sensitive and highly resistant subsets to cytotoxic chemotherapy, we evaluated predictive factors for pCR and PD to NAC, and assessed the similarities in these factors...
Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapyNaoko Honma
Research Team for Geriatric Diseases, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
J Clin Oncol 26:3727-34. 2008..A large and systematic study is needed to address these important issues...
Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancerKeiichiro Tada
Department of Breast Surgery, Cancer Institute Hospital, Tokyo, Japan
World J Surg Oncol 8:6. 2010..The impact of sentinel lymph node biopsy on breast cancer mimicking ductal carcinoma in situ (DCIS) is a matter of debate...
Oestrogen receptor-beta1 but not oestrogen receptor-betacx is of prognostic value in apocrine carcinoma of the breastNaoko Honma
Research Team for Geriatric Diseases, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
APMIS 116:923-30. 2008..ER-beta1 itself, independent of ER-alpha expression and tamoxifen treatment, seems to have a tumor-suppressive effect, at least in apocrine carcinomas. Further study of ER-beta1 is desired to optimize breast cancer treatment...
Clinicopathologic study of 53 metaplastic breast carcinomas: their elements and prognostic implicationsRin Yamaguchi
Department of Pathology, Cancer Institute of Japanese Foundation for Cancer Research, Tokyo 135 8550, Japan
Hum Pathol 41:679-85. 2010..The presence of high-grade spindle cells in metaplastic breast carcinoma may indicate aggressive behavior...
Intraoperative molecular assay for sentinel lymph node metastases in early stage breast cancer: a comparative analysis between one-step nucleic acid amplification whole node assay and routine frozen section histologyTomo Osako
Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
Cancer 117:4365-74. 2011..The authors compared the performance in intraoperative detection of sentinel lymph node metastases with OSNA assay using a whole lymph node versus routine frozen section (FS) histology with a 2 mm-sectioned lymph node...
Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancerYoshinori Ito
Department of Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research Breast Center, International University of Health and Welfare Mita Hospital, Tokyo, Japan
Cancer Sci 102:130-6. 2011..However, this study suggests that a randomized phase II study is a robust tool for obtaining a rapid conclusion on the usefulness of biomarkers and could be the foundation for further large clinical trials...
Clinicopathological significance of invasive micropapillary carcinoma component in invasive breast carcinomaYoshimi Ide
Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
Pathol Int 61:731-6. 2011..The presence of IMP components was a significant predictive factor for nodal metastasis, even if it is detected in only a small proportion of the tumor...
Skin invasion and prognosis in node negative breast cancer: a retrospective studyKeiichiro Tada
Department of Breast Surgery, Cancer Institute Hospital, Tokyo, Japan
World J Surg Oncol 6:10. 2008..The impact of skin invasion in node negative breast cancer is uncertain...
Histogenesis of metaplastic breast carcinoma and axillary nodal metastasesTomo Osako
Division of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Koto ku, Tokyo, Japan
Pathol Int 59:116-20. 2009..This suggested that the ductal component metastasized to the nodes and that epithelial-mesenchymal transition subsequently occurred within the nodes...
Apocrine metaplasia of breast cancer: clinicopathological features and predicting responseAkiko Ogiya
Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Koto ku, Tokyo, Japan
Breast Cancer 17:290-7. 2010..We thus considered that apocrine metaplasia (AM) might represent a predictive marker for breast cancer...
Carcinoma in a solitary intraductal papilloma of the breastRin Yamaguchi
Department of Pathology, Cancer Institute Hospital, Tokyo, Japan
Pathol Int 59:185-7. 2009..An additional partial mastectomy was performed after the lumpectomy but no carcinoma foci were noted in the excised tissue. Possible occurrence of cancerous change in solitary intraductal papilloma of the breast was suspected...
A case of carcinosarcoma of the breastNahomi Tokudome
Department of Breast Pathology, The Cancer Institute, 3-10-16 Ariake, Koto-ku, Tokyo 135-8550, Japan
Breast Cancer 12:149-53. 2005..Such tumors are very rare, and there have been no detailed reports of recurrence patterns of carcinosarcoma. Here we report our pathological findings in detail...
Intraductal papilloma with bloody discharge from Montgomery's areolar tubercle examined by ductoscopy from the areolaTakehiko Sakai
Breast Pathology Section, Cancer Institute, Japanese Foundation for Cancer Research, 3 10 6, Ariake, Tokyo 135 8550, Japan
Breast Cancer 13:104-6. 2006..Although there are a few breast carcinomas that cause bloody discharge and eruption of areola, areolar preservation should be performed with the knowledge that disease may also involve the areola through the lactiferous ducts...
Therapeutic strategies for breast cancer based on histological typeFutoshi Akiyama
Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, 3 10 6 Ariake, Koto ku, Tokyo 135 8550, Japan
Breast Cancer 16:168-72. 2009..Histological diagnosis is also significant from the viewpoint of drug sensitivity, and it is important to maintain the accuracy of histological diagnosis...
Breast cancer associated with mammary hamartomaMasaya Kai
Department of Breast Surgery, Cancer Institute Hospital, 1 37 1 Ariake, Koto ku, Tokyo, Japan
Breast Cancer 19:183-6. 2012..We describe a case of invasive ductal carcinoma arising in the mammary hamartoma during the follow-up period of a previously diagnosed hamartoma...
[Histological features of breast cancer as predictive factors for chemotherapy]Rie Horii
Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research
Nippon Rinsho 65:160-4. 2007
[Evaluation of hormone receptor in breast cancers and the prognosis]Yuko Date
Department of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research
Nippon Rinsho 65:555-8. 2007
High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancerMasataka Sawaki
Department of Medical Oncology, Cancer Institute Hospital and Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
Breast Cancer 13:172-8. 2006..We have summarized a single-center experience involving IBC patients. Our objectives are to clarify molecular alterations of HER-2/neu and p53 in IBC and to investigate the prognostic factors...
Present state of and problems with core needle biopsy for non-palpable breast lesionsTakuji Iwase
Department of Breast Surgery, Cancer Institute Hospital, Tokyo 135-8550, Japan
Breast Cancer 13:32-7. 2006....
